Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2003
03/05/2003EP1286657A1 Nasal ointment based on white petroleum jelly
03/05/2003EP1286652A2 Skin protectant spray compositions
03/05/2003EP1286643A2 Drug containing polymeric micelles
03/05/2003EP1173138B1 Cosmetic or pharmaceutical utilisation of nanoscalic metal soaps
03/05/2003EP1131059B1 Dry powder for inhalation
03/05/2003EP1115406A4 Sustained release, and comfortable ophthalmic composition and method for ocular therapy
03/05/2003EP1095162A4 Archiving of vectors
03/05/2003EP1089714B1 Processes to generate particles of water-insoluble compounds of up to 2000 nm in size
03/05/2003EP0991641B1 Crystalline form of omeprazole sodium salt
03/05/2003EP0971692B1 Specific magnetosome, method for the production and use thereof
03/05/2003EP0969819B1 New crystalline form of omeprazole
03/05/2003EP0952829B1 Pharmaceutical composition of fenofibrate with high biological availability and method for preparing same
03/05/2003EP0946144B1 Polymeric foam reservoirs for an electrotransport delivery device
03/05/2003EP0939622B1 Porous microcapsules and their use as therapeutic and diagnostic vehicles
03/05/2003EP0930070B1 Stable aspirin ointment preparations
03/05/2003EP0895474A4 Liquid eye drop composition
03/05/2003EP0869847B1 Electrostatic coating
03/05/2003EP0835262B1 Method for the treatment of corticosteroid induced osteopenia
03/05/2003EP0822824A4 Method of pretreating viable tissue or cells to be contained within a semipermeable vessel
03/05/2003EP0782441B1 Pharmaceutical control of inflammation
03/05/2003EP0731688B1 Aerosol drug formulations for use with non-cfc propellants
03/05/2003EP0712293B1 Method of preparing gas-filled lipid microspheres and gas-filled lipid microspheres
03/05/2003EP0575524B1 Products for treating glaucoma
03/05/2003EP0554352B1 A method for transplanting cells into the brain and therapeutic uses therefor
03/05/2003CN2538345Y Transfusion system with antiallergic agent rubber bag
03/05/2003CN1400903A Novel combination of non sedative anti histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjuncitivitis
03/05/2003CN1400902A Oral formulation comprising an inhibitor compound of the ileal bile transport and on HMG CO-A reductase inhibitor
03/05/2003CN1400901A Method for reducing or tliminating smoking
03/05/2003CN1400897A Transdermal delivery LASOFOXIFENE
03/05/2003CN1400896A Ibuprofen containing active agent preparation
03/05/2003CN1400894A Plaster containing an active agent
03/05/2003CN1400893A Delivery systems using preformed biodegadable polymer compositions and methods
03/05/2003CN1400892A Pharmaceutical composition for intramuscular injection containing loxoprofen
03/05/2003CN1400870A Improved pediatric formula and methods for providing nutrition and improving tolerance
03/05/2003CN1400268A Material with matter protected by deformable interval structure and its production process
03/05/2003CN1400014A Cordyceps capsule and its preparation method
03/05/2003CN1400013A Preparation method of cordyceps powder preparation
03/05/2003CN1400011A Chinese medicine ointment preparation for curing hyperosteogeny, pain and numbness and its production method
03/05/2003CN1400009A Slowly-releasing medicine membrane for curing perforation of tympanic membrane
03/05/2003CN1400004A Chinese medicine preparation for curing chronic conjunctivitis
03/05/2003CN1399995A Chinese medicine preparation containing cortex fraxini and its preparation method
03/05/2003CN1399980A Adhesive plaster for curing osteomyelitis
03/05/2003CN1399976A Chinese medicine powder preparation for resisting thrombosis and its preparation method
03/05/2003CN1399958A Taxol nano magnetic target preparation and its preparation method
03/05/2003CN1399956A Sanjiao tablet preparation
03/05/2003CN1399955A Method for using nano technological process to prepare Chinese medicinal material and health-care food ultramicroparticles
03/05/2003CN1399954A Astragalus root nano microgranules preparation method
03/05/2003CN1102614C Polymer gel composition and uses therefer
03/05/2003CN1102410C Mupirocin calcium salt emulsifiable paste composition
03/05/2003CN1102408C Stable, aqueous alpha interferon solution formulations
03/05/2003CN1102407C Antidepressive capsule and preparing process thereof
03/05/2003CN1102404C Superfine american ginseng capsule and preparation thereof
03/05/2003CN1102398C Eye ointment for curing myopia and its production process
03/05/2003CN1102397C Chinese angelica root oil soft capsule and its preparing process
03/05/2003CN1102392C Quick soluble breviscapine B tablet its preparation
03/05/2003CN1102390C Fase dissolving galanthamine hydrobromide tablet
03/05/2003CN1102389C External-use drops for earand its prepn. method
03/05/2003CN1102385C Rapidly disintegrating medicinal form of tramadol or tramadol salt
03/05/2003CN1102384C Patch containing isosorbide dinitrate
03/05/2003CN1102383C Preparation of respirable particles
03/05/2003CN1102382C Preparation and methods for the treatment of T cell mediated diseases
03/05/2003CN1102380C Desensitising toothpaste
03/05/2003CN1102351C Health care food having functions of reducing weight andpreventing cardiovascular disease and preparing process thereof
03/04/2003US6528661 Providing atorvastatin ester derivative; converting the atorvastatin ester derivative to atorvastatin hemi-calcium with calcium hydroxide
03/04/2003US6528581 Coating bituminous substrates
03/04/2003US6528575 Crosslinked polymers obtainable by precipitation polymerization; cosmetics, pharmaceuticals
03/04/2003US6528545 Surfactant, perfluorooctyl bromide; superior emulsion stability and controlled particle sizes
03/04/2003US6528542 Adjustment concentration
03/04/2003US6528540 Administering by injection
03/04/2003US6528539 And propylene glycol dicaprate/dicaprylate hydrophobic agent
03/04/2003US6528521 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
03/04/2003US6528516 Methods for reducing intraocular pressure using A3 adenosine receptor antagonists
03/04/2003US6528511 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
03/04/2003US6528483 Method of producing concentrated non-buffered solutions of fibronectin
03/04/2003US6528097 Sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
03/04/2003US6528096 Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation
03/04/2003US6528095 Treatment of any of the following conditions in mammals: atherosclerosis, thrombosis, unacceptable levels of free radicals, long fibrin clot lysis times, unwanted fibrin clot characteristics, unacceptable levels of free fatty acids and
03/04/2003US6528094 Storage stable, shaped particles of allotropic organic compounds. The particles of the present invention can be shaped according to the desired application. Preferred shapes of such particles are microspheres,
03/04/2003US6528093 Sustained-release preparation
03/04/2003US6528092 Synthetic membranes and micelle-like structures comprising lipo-glycoprotein membranes
03/04/2003US6528091 A method of treating epilepsy comprising administering once daily to a patient in need of such treatment a controlled release tablet dosage form comprising a daily therapeutic dose of divalproex sodium from about 50 to 55 weight percent in a
03/04/2003US6528090 Controlled release formulation of divalproex sodium
03/04/2003US6528089 Solid dosage forms are obtained by mixing at least one polymeric binder, at least one active ingredient, and additives to form a plastic mixture, and shaping, using as polymeric binder a copolymer of an N-vinyllactam
03/04/2003US6528088 Highly flexible starch-based films
03/04/2003US6528087 Kits for forming protein-linked lipidic microparticles
03/04/2003US6528086 Methods and apparatus for drug delivery involving phase changing formulations
03/04/2003US6528084 Composition and method
03/04/2003US6528080 Flowable, biocompatible, branched thermoplastic polymer used to form solid matrices such as implants and controlled-release, drug-formulations in a body
03/04/2003US6528077 Cataplasms containing vitamin C or its derivative
03/04/2003US6528074 Lipid composition containing a liquid crystal structure
03/04/2003US6528067 Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
03/04/2003US6528048 Ophthalmic solutions
03/04/2003US6528040 EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
03/04/2003US6528039 Low density microspheres and their use as contrast agents for computed tomography and in other applications
03/04/2003US6528035 Multiwall polymeric microcapsules from hydrophilic polymers
03/04/2003US6527762 Thermally-activated microchip chemical delivery devices
03/04/2003US6527744 Fluid delivery device with light activated energy source
03/04/2003US6527151 Aerosol air flow control system and method
03/04/2003CA2400565A1 Biomodulated multiparticulate formulations
02/2003
02/28/2003CA2399567A1 Crystalline material